(Q43931585)
Statements
1 reference
A phase 3, multicenter, open label, randomized study of abarelix versus leuprolide plus daily antiandrogen in men with prostate cancer (English)
1 reference
John Trachtenberg
1 reference
Marc Gittleman
1 reference
Christopher Steidle
1 reference
Winston Barzell
1 reference
William Friedel
1 reference
Dennis Pessis
1 reference
Nick Fotheringham
1 reference
Marilyn Campion
1 reference
Marc B Garnick
1 reference
Abarelix Study Group
1 reference
1 April 2002
1 reference
1 reference
167
1 reference
4
1 reference
1670-1674
1 reference
Identifiers
1 reference
1 reference